← Back to results

Posted · PA-07-089

HIV Infection Of The Central Nervous System (R01)

National Institutes of Health  ·  HHS

CFDA Numbers

93.242, 93.273, 93.279, 93.853

Award Ceiling

Award Floor

Expected Awards

Close Date

Section I

How to Apply

Apply Online ↗

View on grants_gov ↗

Program Contact

NIH OER Webmaster<br/>FBOWebmaster@OD.NIH.GOV<br/>
FBOWebmaster@OD.NIH.GOV

Section II

Eligibility

Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith-based or community-based organizations can apply.

Eligible Applicant Types

00, 01, 02, 04, 05, 06, 07, 08, 11, 12, 13, 20, 22, 23, 25

Section III

Description

-Purpose. The purpose of this Funding Opportunity Announcement (FOA) is to invite grant applications to support research focused on determining the pathogenic mechanisms involved in Human Immunodeficiency Virus (HIV)-1 associated neurobehavioral and neurological dysfunction in domestic and international settings. The objective of this cooperative effort is to foster investigations that will provide the foundation for the rapid development of therapeutic interventions to prevent and treat the effects of HIV-1 on the central nervous system (CNS). Applications ranging from basic research to clinical diagnosis and treatment are of interest. Multidisciplinary research teams and collaborative alliances are encouraged but not required. -Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award mechanisms. Applications of related or identical scientific scope are also solicited under the Small Research Grant (R03) and the Exploratory/Developmental Grant (R21) award mechanisms, responding to FOAs PA-06-180 and PA-06-181), respectively.

Section IV

Key Dates

Posted
Nov 22, 2006
Archive
Oct 2, 2010